DSIP
Delta Sleep-Inducing Peptide
DSIP (Delta Sleep-Inducing Peptide) is a neuropeptide first isolated in 1974 from rabbit cerebral venous blood during slow-wave sleep. As its name implies, it was discovered for its ability to induce delta (slow-wave) sleep — the deepest, most restorative stage — but subsequent research has revealed broader neuromodulatory, stress-modulating, and neuroprotective effects.
At a Glance
DSIP's mechanism is not fully characterized — it doesn't act on a single well-defined receptor like most research peptides. Instead, it appears to modulate multiple systems simultaneously: ACTH/cortisol signaling, delta EEG oscillations, LH pulsatility, and potentially opioid receptor tone.
This broad modulatory profile explains both its diverse research applications and the difficulty in pinning down a single mechanism of action — DSIP behaves more like a state-modulating neuropeptide than a single-target pharmacological agent.
Alcohol and opiate withdrawal research represents one of its more unexpected applications — DSIP has shown efficacy in reducing withdrawal symptoms in small clinical trials, suggesting relevance to addiction neuroscience beyond sleep.
This compound operates through several converging biological pathways, which helps explain the breadth of effects observed across different tissue and metabolic models.
Delta Sleep Induction
Increases slow-wave (delta) sleep duration and quality — the stage associated with growth hormone secretion, memory consolidation, and physical recovery.
HPA Axis Modulation
Modulates ACTH and cortisol secretion — studied in stress response research for normalization of dysregulated HPA axis activity.
LH Pulse Modulation
Affects pulsatile LH secretion — connecting sleep regulation research to reproductive axis neuromodulation.
Neuroprotection
Showed protective effects against oxidative stress and excitotoxicity in preclinical CNS models — a secondary research dimension beyond sleep.
Preclinical and clinical models have investigated this compound across a wide range of physiological contexts and tissue types.
- Slow-wave sleep enhancement — primary research application; delta EEG promotion
- Stress and HPA axis modulation — ACTH/cortisol normalization research
- Alcohol and opiate withdrawal — symptom reduction in small clinical trials
- Growth hormone research — slow-wave sleep and nocturnal GH pulse connection
- Insomnia models — delta sleep promotion without sedative mechanism
- LH pulsatility research — neuroendocrine connections to sleep architecture
- Neuroprotection — oxidative stress and excitotoxicity models
DSIP's 50-year research history represents one of the longest tracks of any neuropeptide research compound — though its complex, multi-system mechanism has kept it from becoming a clean pharmaceutical target.
DSIP, Selank, and Epitalon represent three different angles on sleep research — direct delta induction, anxiety-mediated onset, and circadian/melatonin restoration.
| Aspect | DSIP | Selank | Epitalon |
|---|---|---|---|
| Primary Effect | Delta sleep induction | Anxiolytic, GABA modulation | Telomerase, pineal/melatonin |
| Sleep Mechanism | Direct delta oscillation modulation | Anxiety reduction → better sleep | Melatonin restoration |
| Stress Effects | HPA axis normalization | GABA/anxiety pathway | Indirect (aging) |
| Evidence Base | Moderate preclinical + small clinical | Russian clinical data | Russian long-term data |
| Best Research Use | Sleep architecture, HPA | Anxiety, sleep onset | Longevity, melatonin |
The following reflects findings from published preclinical and clinical safety assessments where available.
50-year research history — one of the oldest neuropeptide research compounds with established preclinical characterization
Multi-system modulation — sleep, HPA axis, and LH pulsatility in a single compound
Non-sedative mechanism — promotes deep sleep without the sedation, tolerance, or dependence of GABA-acting sleep drugs
Mechanism not fully characterized — unlike receptor-specific peptides, DSIP's multi-target profile complicates mechanistic isolation
This overview is strictly educational and based on publicly available scientific literature as of 2026. It does not constitute medical advice. All Helixera Labs products are for laboratory research use only. Not for human or veterinary use. · Helixera Labs LLC © 2026